• PULL expands into EU through initial sale of cannabis oil extracts to German pharmaceutical company
• Sale to Germany expected to pave way for additional supply agreements throughout Europe
• Company orders first shipment of functional mushroom products for direct-to-consumer e-commerce portal, expects $15,000 gross monthly sales for each formulation
• PULL’s new state-of-the-art facility constructed to EU GMP standards for worldwide exports

With a focus on the cannabis, hemp, functional mushrooms and rapidly emerging psychedelic sectors, Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a Canadian plant-based extraction company, is steadily increasing its market share through the achievement of several important milestones. Along with the Company’s first shipment of functional mushrooms for its e-commerce portal, Pure Extracts has expanded into the European Union (“EU”) through an initial sale of cannabis oil extracts to a German pharmaceutical company.

Germany is one of the largest and most innovative economic markets in Europe (https://ibn.fm/ivhQF). Pure Extracts’ management expects the initial sale will lead to more long-term supply agreements and additional export opportunities to other EU countries where the Company’s products can be legally sold. With a focus on the medical cannabis sector, the Company purchases Canadian-grown, EU-GMP-certified, dry cannabis flower and extracts it into 85% pure THC distillate and 70% pure THC full spectrum oil (“FSO”) that can be processed into an ultra-pure form of THC for medicinal purposes.

“It is gratifying to have had our concentrates selected by a German pharmaceutical company for use in their medical products,” said Pure Extracts CEO Ben Nikolaevsky (https://ibn.fm/Kpdwa). “We are excited about the entire European market opportunity for our extracts.”

Along with prospective domestic and international supplier agreements, Pure Extracts will also sell its functional mushroom wellness products online through its direct-to-consumer e-commerce portal. The Company recently ordered its first shipment of functional mushrooms from its British Columbia co-packer and plans to have Reishi and Maitake formulations available in April followed by the addition of a Lion’s Mane formulation by the end of Q2 with expected gross sales of $15,000 per month for each product.

“We are excited to be ordering the first Pure Mushrooms products to launch our direct-to-consumer, online store,” said Nikolaevsky (https://ibn.fm/Vjp9a). “The functional mushroom wellness market is experiencing robust sales as many consumers are trying to boost their immune systems in light of the COVID-19 pandemic. As we build out our mushroom extraction facility, we plan to bring more products to market.”

Pure Extracts is now trading on the Canadian Securities Exchange under the symbol “PULL”, the Frankfurt Stock Exchange under “A2QJAJ”, and the U.S. OTC market under “PRXTF”. The Company’s state-of-the-art newly constructed processing facility is built to EU GMP standards with the aim of exporting products globally to locations where their sale and consumption are permitted. As the market for functional and medicinal psychedelic products gains traction worldwide, Pure Extracts is poised to gain significant market share through its commitment to developing first-in-class extracts for the rapidly growing functional and medicinal plant-based medical industry.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

• Convergence of AI, big data and biology allows Helomics to test drugs on living tumor tissue rather than artificial systems
• Helomics model evaluates multiple measurements in powerful multi-omics approach to cancer research
• Knowledge encapsulated by Helomics AI is “gold dust,” says chief innovation officer

Data, AI and biology come together at Helomics in a way that promises exciting things for the future, according to  Mark Collins, PhD and chief technical officer at the company, which is a subsidiary of Predictive Oncology (NASDAQ: POAI) (https://ibn.fm/ms1hL). Collins was a guest speaker on a DojoLIVE! podcast titled “Can We Cure Cancer with Artificial Intelligence?” where he discussed what Helomics is bringing to the table in the field of cancer research.

“At Helomics, we have a nice convergence of data that we’ve gathered from testing live tumors, tumors outside the patient body, on drugs, standard of care drugs, normal drugs that you might get if you were diagnosed with cancer,” he said. “We have a massive collection of data that goes along with that drug response — over 150,000 tumors, which is a huge data set. And then again we have AI. And it’s that convergence of AI, the big data if you will, and the biology that means we’re able to test drugs on living tumor tissue rather than some artificial system that is really what’s driving what we do.”

During the podcast, Collins explained what makes Helomics distinctive.

“We don’t just look at one aspect of the tumor,” he said. “We look at multiple, as it were, measurements of that tumor. How it responds to drugs, what it looks like, what mutations it has in its DNA, how different genes are expressed, so it’s what we call a multi-omics approach. . . . Cancer is so complex, the human body is so complex, it’s not going to be just down to one thing that’s driving how the tumor or the patient responds to drugs.”

Collins pointed out that Helomics currently specializes in ovarian cancer. “We developed and have a validated clinical assay where we take a sample from the patient following surgery to remove the tumor,” he explained. “We grow that tumor in the lab, we test drugs on it, we look at different mutations in the tumor, and then we compare that with the data that we have in our database, and we feed that back to the oncologist to guide treatment.”

The company doesn’t make a recommendation or prescribe medication, but the information Helomics provides helps the clinician determine drug treatment. “This drug response profile that we can generate really moves the needle for patients,” Collins said. “And in our clinical validation studies we can show that if the clinician chooses the drug that was indicated by this drug response assay, that we can extend the disease-free period for about two and half times longer than if they didn’t follow that recommendation.”

While AI isn’t a part of this particular process at the moment, Collins says the expectation is that it soon will be. “We’re doing a study with a local hospital in ovarian cancer where we expect to be able to produce a predictive model that will predict what drug [the patient] should be on and what outcome you’ll have. Now we have to clinically validate that before we can use it to individualize treatment,” he continues, “so it will be a couple of years before the AI is making those kinds of clinical decisions. But because the AI has encapsulated all this knowledge about the tumor, that is gold dust. Pharma companies are becoming very interested in these kind of models that use real world data and can help them discover new therapies in a much more knowledge-driven way than they perhaps do at the moment.

“AI will also help us discover drugs in the not-too-distant future,” Collins concludes. “Faster because we do less experimentation, smarter because we use the machine learning. Coupling adaptive learning (a special kind of machine learning) together with our data allows us to decide which experiments to do, and then we do those experiments using the right biology which is our live tumor testing platform. Certainly, pharma companies that we’ve already talked to are beginning to see that this kind of union between simulation, AI, big data and relevant biology is really going to make a difference to our ability to make new medicines for cancer.”

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of more than 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• Mohawk Group Holdings Inc. has announced its Q4 and full-year 2020 results
• The Q4 Net Revenue Grew 61.9% Year-Over-Year to $41.5 Million from $25.6 million in Q4 2019
• The company’s full-year operating loss of $(34.8) million improved from $(54.3) million in 2019

Mohawk Group Holdings (NASDAQ: MWK) is a CPG (Consumer Packed Goods) platform concentrated on developing proprietary technology using data and artificial intelligence to operate and manage consumer product brands. AIMEE(R) (AI Mohawk E-commerce Engine) is the company’s next-generation E-commerce platform that employs the latest technologies to launch new CPG products and identify market opportunities. These CPG products constitute 12 brands in multiple categories ranging from kitchenware, consumer electronics, and home appliances to environmental appliances. The company recently announced its Q4 and Full-Year 2020 results, some major highlights are as below:

• Full-year net revenue grew by 62.3% year-over-year to $185.7 million, from $114.5 million in the full year of 2019. The fourth-quarter net revenue grew 61.9% to $41.5 million, from $25.6 million in the fourth quarter of 2019
• The full-year gross margin improved to 45.6% as compared to 39.4% in 2019. The fourth-quarter gross margin improved to 45.2% compared to 35.4% fourth quarter of 2019
• Full-year operating loss of $(34.8) million improved from $(54.3) million in 2019. Full-year operating loss includes $12.7 million of loss related to change in fair value of potential future performance-based earnouts from acquisitions and $22.7 million of non-cash stock compensation
• The company’s actual quarterly loss of $0.33 per share compares to a loss of $1.06 per share a year ago. These figures are adjusted for non-recurring items

The company’s detailed 2019 Q4 result reports are available at https://ibn.fm/bv7lh. The quarterly net revenue grew 61.9% year-over-year and although they are still operating at a net loss as they grow, their full-year operating loss showed significant improvement from 2019 (https://ibn.fm/gqIGD). For more information, visit the company’s website at www.Mohawkgp.com. NOTE TO INVESTORS: The latest news and updates relating to MWK are available in the company’s newsroom at https://ibn.fm/MWK

• ISW Holdings adds two revolutionary POD5IVE datacenters, triples its cryptocurrency mining fleet
• Each new datacenter brings potential $2.9 million in annualized revenues
• ISWH firmly committed to strategic vision for cryptocurrency mining amid record-high margins and growing acceptance of cryptocurrency assets

ISW Holdings (OTC: ISWH), a diversified global portfolio company comprised of essential business lines focused on telehealth and cryptocurrency mining, recently boosted its active cryptocurrency mining fleet with additional POD5IVE datacenters (https://ibn.fm/7NaNw). Despite inevitable pandemic-related supply chain challenges, ISWH managed to add two POD5IVE datacenters. With these newly added units, the company effectively tripled its initial mining fleet; the company now operates three POD5IVE data center units, expected to significantly impact its financial fundamentals. ISWH’s Pod5 Cryptocurrency Mining Pod is a fully self-contained, high-PUE mining solution designed, assembled and installed in partnership with Bit5ive LLC at the Bit5ive 100 MW renewable energy cryptocurrency mining facility in Pennsylvania. The pod’s elegant, powerful and efficient design provides revolutionary dynamic plug-and-play operation that offers industry top-of-the-range 1.06 power usage effectiveness score. Self-managed and with virtually no maintenance requirements, this state-of-the-art datacenter pod is a unique cryptocurrency mining equipment solution. ISW Holdings began implementing a four-phase growth plan last year. Phase 1 and 2, which involved developing the design and establishing a supply chain to build its revolutionary Pod5 mining solution in partnership with Bit5ive, has been completed. Further advancement on the path towards robust growth continues with phase 3, which includes the mining launch, targeting revenue generation from participation in the Bit5ive Pennsylvania project and expanding the mining activities through additional Pod5 units. The final phase 4 will include further expansion in total mining capacity and initial sales of Pod5 units, with the support from the company’s Bit5ive partnership and the track record from phase 3 operations (https://ibn.fm/LolCG). The expansion phase involves assembling, equipping and powering up additional Pod5 units that can house 300 miners each. Every unit represents approximately $2.9 million in annualized revenue-generating opportunity from mining activities at current market prices. ISW Holdings’ strategic vision for its cryptocurrency segment is based on fundamental confidence in the long-term viability of cryptocurrency as store of value and platform for global commerce. Aligned with that vision, the company is committed to invest, expand and capitalize on its robust investments made from May of last year at a time when margins are at historical levels following further strength in the value of cryptocurrency assets. “As we continue to bring our miners online, we want our shareholders to be able to track the expansion and profitability of the company’s mining activity given the sharp rising trend in Bitcoin prices,” said ISW Holdings president and chairman Alonzo Pierce. Cryptocurrency assets have seen significant uphold from prominent corporate, financial and regulatory players over the past year. All of this contributes to the increasing mainstream acceptance of crypto-assets, putting the company in a strong position given its early investment in developing the Pod5 last year. Based in Nevada, ISW Holdings is a diversified portfolio company comprised of essential business lines that serve consumer product demands. The company’s expertise lies in strategic brand development and early-growth facilitation, as well as brand identity through its proprietary procurement process. Together with its partners, ISWH seeks to provide a structure that meets large scalability demands as well as anticipated marketplace needs. ISWH maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency. For more information, visit the company’s website at www.ISWHoldings.com. NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

Stabilis Solutions (OTCQX: SLNG) is a vertically integrated energy transition company that provides clean energy solutions including small-scale liquefied natural gas (“LNG”) and hydrogen production, distribution and fueling services to multiple end markets in North America. As one of the continent’s most experienced small-scale LNG providers, Stabilis has safely provided over 250 million gallons of LNG through more than 25,000 truck deliveries during its 16-year operating history in the industry.

While serving a host of diverse markets such as aerospace, mining, energy, utilities and pipelines, commercial, and high horsepower transportation, Stabilis delivers solutions for cheaper, cleaner fuel. Stabilis is poised for massive growth opportunities in Mexico, where the Company recently completed the largest distributed natural gas project in Mexican history. The Company has also expanded its project pipeline, resulting in a potential to yield more than $200 million in new projects over the next several years.

As a turnkey provider of clean production, storage, transportation and fueling system solutions for LNG and hydrogen across North America, Stabilis takes great pride in its mission to reduce harmful emissions and partner with renewable energy while offering cost-effective solutions that support growth without requiring subsidies. LNG is the cleanest fossil fuel, representing an excellent alternative to reduce greenhouse gas emissions and help combat global warming. Stabilis’ Enlightened Energy™ is the bridge to renewables desperately needed to shift to a cleaner economy.

To see the recorded presentation delivered at last week’s Investor Summit, visit www.Stabilis-Solutions.com.

• Sales have steadily surged at Splash Beverage from $112,003 for Q1 2020 to $1.24 million in Q4 for $2.98 million for all of 2020
• Bill Meissner, Peter McDonough joined Splash Beverage Group in 2020, bringing decades of executive blue chip experience
• Splash completed $6 million acquisition of Copa Di Vino in early January 2021, made several other growth deals that will continue to improve financial performance in 2021 and beyond

The beverage game is big business—whether it’s alcoholic or non-alcoholic drinks. Some famous actors have put the spirit world on full display in recent years, including George Clooney selling his Casamigos tequila brand for reportedly up to $1 billion (https://ibn.fm/6XGCi) and Ryan Reynolds exiting his Aviator gin brand for up to $610 million (https://ibn.fm/YIpIk). There’s a reason that Dwayne “The Rock” Johnson has jumped into the space with his own tequila and Snoop Dogg is peddling a gin line as well. The beverage sector is experiencing tremendous growth, and while these celebrity brands are receiving a lot of attention, there are dozens of other brands making headlines with massive exits.  Accelerating preexisting brands is the area of specialty for another up-and-comer in the space, Splash Beverage Group (OTCQB: SBEV). By diversifying into both alcoholic and non-alcoholic segments, the Fort Lauderdale, Florida-based company de-risks its future while benefiting from production, supply chain and distribution efficiencies. The company’s brands include TapouT Performance (a hydration and recovery sport drink and partner to World Wrestling Entertainment (NYSE: WWE), SALT Naturally Flavored Tequila, Pulpoloco Sangria and Copa Di Vino wine. Copa Di Vino, “born” on Shark Tank, a leading producer of premium “wine by the glass” in the U.S., is Splash’s latest acquisition, capping a strong 2020 as detailed in the company’s recent 10-K annual report filed with the Securities and Exchange Commission (https://ibn.fm/3wtFZ). The year was transformational for Splash, including a merger in March that brought the company public followed by a ticker change to “SBEV” in July. Splash also made a few key leadership moves in 2020. Bill Meissner joined the team as chief marketing officer and sales president. Meissner has decades of experience in retail beverages, serving as president and/or CEO of Fuse, Sparkling Ice, Jones Soda, Sweet Leaf Tea and others. Additionally, Peter McDonough came on as an independent board member. McDonough has an unparalleled C.V. for sitting on the board of an upstart company, and he brings incomparable marketing experience to Splash. This type of leadership, along with the rest of the seasoned management at Splash, has helped to raise capital for expansion to the tune of $9.0 million through February 2021. Those funds can be used for organic growth and acquisitions, such as the Copa Di Vino buyout in December for $5.98 million. The measured growth initiatives are showing up in the financials, with sales starting in Q1 2020 at $112,003 and rising to $612,308 in Q2, then $1.01 million in Q3 and $1.24 million in Q4 for $2.98 million for 2020. Subsequent to the end of 2020, Splash has continued on a growth trajectory, not only completing the acquisition of Copa Di Vino, but also expanding distribution and sales of Salt Tequila via a deal with the U.S. Coast Guard and landing new distribution agreements for TapouT beverages throughout California, Florida and Alabama. In the upcoming quarters, investors will see how these new additions factor into the pattern of steady growth. For more information, visit the company’s website at www.SplashBeverageGroup.com. NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

• Bladder cancer is the 6th most prevalent cancer in the United States and a problem worldwide
• Bladder cancer is more common in men than women at a 4:1 ratio
• Bladder cancer treatment has the highest cost per patient over the course of a lifetime because of its greater than 50% recurrence rate
• Surgeons, including urologists at the University of Washington, have adopted a solution that uses blue light and a contrast agent to better visualize bladder tumors and has been shown to be more successful and reduce costs
• Imagin Medical has taken this solution one step further by developing the i/Blue Imaging System(TM)
• Imagin’s patented technology is expected to be completed next year, after final manufacturing and FDA approval has been received

Urologists at the University of Washington’s research school of medicine in Seattle discussed a blue light cystoscopy system they use that allows “surgeons to better identify non-muscle-invasive bladder cancer,” and improve resection without leaving cells behind to cause recurrence (https://ibn.fm/sdSC9).

This tool will allow us to do better resections and hopefully improve bladder cancer survival,” UW urology professor Dr. Jonathan Wright stated in a UW Medicine news release (https://ibn.fm/tstAU).

Blue light cystoscopy has been gaining popularity in surgical circles which will be an advantage for Imagin Medical when they enter the market. It involves using a blue light cystoscope inserted through the urethra to detect (with a small camera) tumors that has been fluoresced by a drug that specifically adheres to bladder tumors, better revealing the tumors and their contours. Boston-based Imagin Medical (CSE: IME) (OTCQB: IMEXF) is preparing to launch manufacturing of the i/Blue(TM) Imaging System, a patented technology that will further improve blue light cystoscopies for surgeons and patients.

Imagin’s i/Blue Imaging System advances the blue light procedure by allowing surgeons to see the bladder wall under both white and blue light simultaneously in side-by-side presentation, whereas existing systems require surgeons to toggle back and forth between white and blue during the course of the procedure. Imagin is advancing toward manufacturing and FDA approval of its solution.

Bladder tumor resection involves using an electrified loop to scrape away the tumor from the bladder wall while cauterizing the area to stop bleeding, Wright said (https://ibn.fm/emeiQ). The surgeon’s intent is to remove non-invasive tumors before they penetrate into the muscle, if possible, and o head off a need for more significant treatment such as removing the bladder or using chemotherapy, and to reduce the potential for eventually fatal metastasis of the cancers.

Bladder cancer is the fourth most common cancer in men and directly resulted in more than 17,000 deaths during the past year in the United States, with similar statistics anticipated for 2021 (https://ibn.fm/fUKFU), according to the American Cancer Society.

Seventy percent of bladder cancer patients have non-muscle-invasive disease. That’s the population who can benefit,” Wright added in the news release. “One of the things that we have to do as urologists when we’re evaluating patients with bladder cancer is, the surgical role of resecting is very critical. We need to avoid under-staging and make sure that we’re accurately staging the depth of the tumor invasion, if there is any, because it so much impacts the recommendations.”

Despite those efforts, Daniel Schneider, President and CEO of Photocure ASA, the developer of the tumor-staining chemical, noted in the company’s most recent quarterly earnings report that the high rate of recurrence of bladder cancer makes it important to prepare patients for the possibility expensive repeat procedures in the future.

“(Bladder cancer treatment) is most expensive. And I think that often shocks people. It’s the highest per patient lifetime treatment cost of any cancer,” Schneider said (https://ibn.fm/CkplM). “And the reason is the patients, once diagnosed, will go through a lifetime of procedures. Its recurrence rates are also quite astoundingly high, up 61 percent within the first one year of being diagnosed and 78 percent reoccurrence rates within five years. … It’s key to keep the patient, if you can, in a non-muscle invasive category where treatments are much less invasive.”

The aim of Imagin’s patented i/Blue technology is to ultimately reduce the expense patients will have to deal with and improve their chances of survival. A recent report by Urology Times states that the cost of early intervention in resecting bladder tumors under blue light procedures declined by $4,660 over five years compared with use of white light cystoscopy alone and led to a lower overall burden for patients (https://ibn.fm/qjJCW). A more complete elimination of tumors would be expected to result in reduced cancer progression.

For more information, visit the company’s website at www.ImaginMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

• Perpetual Industries Inc. is expanding expertise and knowledge of energy-efficient technologies through the development of low-cost, green energy solutions for various industries
• The company’s R&D portfolio includes its proprietary XYO Balancing Technology, WindSilo, the XYO Washing Machine and Green Energy Mining (“GEM”) Systems
• The proprietary XYO Balancing Technology is optimized to eliminate vibration in a full spectrum of rotating equipment, creating virtually unlimited market potential
• The company recently acquired Worldwide Auctioneers, a classic car auction company
• The company’s boasts a seasoned management team led by Founder Brent W. Bedford, who has held the positions of President, Chairman and CEO since the company’s founding in 2005
• The global renewable energy market is expected to reach $1.5 trillion in 2025, expanding at a CAGR of 6.1%

Perpetual Industries (OTC: PRPI) is an incubator for the development of innovative, energy-efficient technologies aimed at commercializing products that have the potential to impact and advance a wide range of industries on a global scale. The company’s team of experts and trusted industry partners have the resources to provide essential components needed to take projects from their initial stages through to the end products. Perpetual Industries values strict controls and high levels of quality through all stages of research, development, manufacturing and commercialization. Perpetual Industries was founded by President, Chairman and CEO Brent W. Bedford in 2005. It is located in Auburn, Indiana. R&D Portfolio Overview Perpetual Industries is expanding expertise and knowledge of energy-efficient technology by developing low-cost, green energy solutions for various industries, including artificial intelligence, blockchain mining, graphic rendering, renewable energy, cloud computing and internet of things (“IoT”), all while continuing research, development and commercialization of its proprietary XYO Balancing Technology in key applications. XYO Balancing Technology XYO Balancing Technology delivers high-performance solutions for inefficiencies that commonly affect rotating equipment, machinery and devices. It is designed to harness rotor displacement energy to move compensating masses and automatically correct for imbalances, effectively reducing vibration. Key highlights of the company’s XYO Balancing Technology include:

• Customized XYO balancers can be created for almost everything that rotates, providing virtually unlimited potential applications
• XYO Balancing Technology is optimized specifically to eliminate vibration in rotating equipment and enable environmentally responsible products to operate more efficiently
• Leveraging a proprietary design, XYO Balancing Technology is the result of over 25 years of research and development effort

WindSilo – Vertical Axis Wind Turbine Implementing its proprietary XYO Balancing Technology, Perpetual Industries’ WindSilo turbine improves balancing issues that are common in most wind turbines today. The company’s design is engineered to allow for much faster spin speeds and greater energy output. The company believes that this innovative turbine design could eliminate the expensive traditional methods of balancing wind turbines while increasing their performance, reliability and efficiency. In November 2020, Perpetual Industries announced that Trine University, a private post-secondary institution located in Angola, Indiana, had been awarded a grant to assist the company in the development of the WindSilo. The XYO Washing Machine Perpetual Industries is currently developing a proprietary domestic washing machine design implementing XYO Mechanical Balancers to dynamically compensate for variable mass imbalance during the spin cycle. The company expects these efforts to produce a number of benefits, including higher spin speeds, reduced energy consumption, decreased noise emissions and less mechanical wear & tear. The company’s research shows tremendous market potential for a more efficient washing machine design. With an estimated 70 million washing machines produced annually and over 500 million used daily, even a small reduction in energy consumption could be pivotal. Reducing energy usage of all washing machines by just 15% would save enough energy to power the city of Milan. Perpetual Industries’ energy efficient design is expected to reduce energy usage by up to 50%. Prototype testing of Perpetual Industries’ design has established the XYO Washing Machine as highly effective at reducing vibration when built into the spin basket assembly. Green Energy Mining System Using its expertise and knowledge of environmentally friendly technologies, Perpetual Industries is developing low cost, environmentally responsible energy solutions for powering large scale blockchain mining operations. The company’s Green Energy Mining (“GEM”) System is being hailed as the next generation of energy efficient cryptocurrency mining. Powered by renewable & surplus energy sources such as wind, solar, natural gas, wind and geothermal that utilize battery storage technology, the platform addresses rising demand for computing power. Renewable Energy Market Outlook The global renewable energy market was valued at $928 billion in 2017 and is expected to continue expanding at a CAGR of 6.1%, resulting in a value of $1.5 trillion by 2025, according to Allied Market Research (https://ibn.fm/C06xF). Hydroelectric power is projected to be the most lucrative segment of the entire global renewable energy industry, followed by the wind, bioenergy, solar and geothermal segments. Worldwide Auctioneers Acquisition In January 2021, Perpetual Industries announced its acquisition of The Worldwide Group LLC, operating as Worldwide Auctioneers. Worldwide Auctioneers is a U.S.-based boutique auction firm specializing in the sale and acquisition of classic vintage motorcars at auction around the globe. With an impressive 20-year history and a talented team, Worldwide offers an extensive range of personalized services to collectors, including private sales, appraisal, collection direction and consultancy, estate planning and asset management. Perpetual Industries expects Worldwide to benefit from multiple channels of collaboration moving forward, particularly within the company’s blockchain division. Classic Car Market Outlook The U.S. classic car market has recorded steady expansion over recent years, accounting for revenue of approximately $12.63 billion in 2020, according to Statista (https://ibn.fm/Fydhj). The same report forecasts growth to $15.52 billion by 2023, representing a CAGR in excess of 7 percent. Classic car dealers in the U.S. have cornered a significant portion of this market opportunity. According to data from IBISWorld (https://ibn.fm/k30F5), the market for classic car dealers in the U.S. was valued at $2.1 billion in 2021, achieving a CAGR of 1.5% from 2016 to 2021, despite the challenges associated with the COVID-19 pandemic. Management Team Brent W. Bedford is the President, Chairman, CEO and founder of Perpetual Industries. He has held these roles continuously since founding the company in January 2005. He has a deep understanding of every aspect of the company’s business, products and markets. He also has experience developing corporate strategies, assessing emerging industry trends and carrying out business operations. Mr. Bedford has a strong background in mechanical applications, with expertise in finance, private startups, public startups and corporate turnarounds. Carl Dilley is Director and COO of the company. He is a career entrepreneur who has served as a C-level officer in many different companies across multiple industries. Mr. Dilley has been instrumental in taking over 400 companies public. He has been involved in the investment industry since 1983. He has held FINRA series 24, 66 and 7 Securities licenses, allowing him to perform retail, investment, banking and new listing services functions. William Griffin Thomas, CPA, is the company’s CFO. He holds a Bachelor of Science in Accounting from the University of Tampa and a Bachelor of Science in Agribusiness from the University of Florida. Mr. Thomas is a licensed CPA with over 19 years of experience spanning both the private and public sectors, as well as time with non-profits. His expertise includes auditing, budget analysis, fixed assets, financial modeling, SEC financial reporting, GAAP compliance and fair value measurements. For more information, visit the company’s website at www.PerpetualIndustries.com. NOTE TO INVESTORS: The latest news and updates relating to PRPI are available in the company’s newsroom at https://ibn.fm/PRPI

• Splash Beverage Group released its annual report for 2020 fiscal year on March 8, 2021
• Company revealed it had achieved dramatic quarter-over-quarter revenue, beginning with $112,003 in Q1 sales, ending with $1,242,013 in Q4 with a total of $2,975,939 in sales for EOY 2020
• SBEV announced it raised gross proceeds of $4 million through private placement in 1Q21, taking total raised funds to over $9 million
• Annual report also contained details on SBEV’s recently completed acquisition of premium wine maker Copa di Vino Corporation as well as latest additions to its management team

Splash Beverage Group (OTCQB: SBEV), a holding company for a leading portfolio of beverage brands, released its Annual Report on Form 10-K for the fiscal year ending December 31, 2020 with the Securities and Exchange Commission on March 8, 2021 (https://ibn.fm/Zsqqo). The annual report touched on the company’s merger with its wholly owned subsidiary in March of last year, which resulted in Splash Beverage Group Inc. as the surviving entity as well as the company’s subsequent ticker change, leading to the common stock being quoted on the OTCQB market under the symbol SBEV. Most notably, the company saw historic quarter-over-quarter revenues, beginning with $112,003 in Q1 sales, $612,308 in Q2, $1,009,615 in Q3 and $1,242,013 in Q4 with a total of $2,975,939 in sales for EOY 2020. SBEV also reported that it had achieved cumulative sales of $2,975,939 in 2020. The company also seized the opportunity to update investors on its ongoing financing activities with Splash Beverage Group raising aggregate proceeds of $4 million in the first quarter of 2021 from a private placement. The placement consisted of the sale of 3,637,064 shares of common stock and warrants, with each warrant entitling the holders to purchase two additional shares at a combined purchase price of $1.10 per share. As of February 22, 2021, Splash Beverage Group had raised over $9 million, resulting in the cancellation of the recission rights held by certain investors as part of the terms of their conversion agreements. Splash Beverage Group additionally announced its completion of an Asset Purchase Agreement with Copa di Vino Corporation – a leading producer of premium wine by the glass based in The Dalles, Oregon – as of December 24, 2020, with the acquisition serving to further the company’s alcoholic beverage portfolio. SBEV agreed to purchase certain assets and assume certain liabilities comprising the Copa di Vino business for a total purchase price of $5,980,000. The purchase served to broaden Splash Beverage Group’s product portfolio to a total of four unique beverage brands, including TapouT Performance, a natural isotonic hydration & recovery sports drink; Salt Naturally Favored Tequila; Copa di Vino premium wines packaged in single servings; and Pulpoloco Sangria, a premium crafted sangria imported from Spain. Splash Beverage Group also highlighted the addition of several prominent figures to its executive management team, including Bill Meissner, who joined the company as chief marketing officer and sales president on May 20, 2020. Meissner came to the company boasting a significant track record within the North American beverage industry, having previously served as president and/or CEO of Fuse, Sparkling Ice, Jones Soda and Sweet Leaf Tea, among others. SBEV also announced that Peter McDonough has joined Splash Beverage Group as an independent board member. Mr. McDonough, who joined as an independent director on March 31, 2020, had previously served as president and chief marketing and innovation officer for Diageo North America from 2006 to 2015, having worked in a senior capacity at Procter & Gamble prior to that. For more information, visit the company’s website at www.SplashBeverageGroup.com. NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

• Nextech AR Solutions, an augmented Reality company is projecting revenues going from $20mill in 2020 to over $50 million for 2021.
• Nextech’s Platform (“VXP”) chosen to host the Student Veterans of America’s (“SVA”) 2021 National Conference in February Featuring first lady Dr. Jill Biden.
• The company is working towards introducing a new NFT technology for what is considered “the holy grail of AR” a LIVE volumetric human hologram in their AiRShow app.
• Nextech AR launched its AR AD Network which will be generating reveue off it’s owned and operated digital platfoms this month.

Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF) is a Vancouver-based augmented reality company focusing on e-commerce, education, hybrid events, and more, using its AR 3D network. An article on Nextech’s development and projects read that the company is projecting revenues over $50 million for 2021. The company’s Q4 2020 bookings were recorded at $7.3 million (estimated), marking a greater than 235% year-over-year increase. The company recorded a mammoth 235% revenue growth for calendar 2020, reporting $20 million for the 12 months. The web-based AR platform attributes its success to the newly launched 3D ad network that has secured the company new and existing contracts along with conversions from the e-commerce channels. The company is exploring the launch of a NFT marketplace: A Non-Fungible Token, or NFT, is a unique identifier on a blockchain such as Ethereum that represents verified ownership of digital assets. NFTs are becoming increasingly prevalent within the realm of digital content and can be used to represent tangible and intangible assets, such as music, digital artwork, video, and virtual or augmented reality assets. Nextech’s AR NFT marketplace when launched will be used initially to create meaningful transactions that live forever as NFT enabled AR experiences. The Company’s AiR Show mobile app which is currently available globally on iOS and Android was created for musicians to be able to beam themselves into people’s living rooms as a hologram and put on a performance. The Company believes these performances in the app will be a perfect NFT enabled use case. Each musician’s performance can be unique, rare, collectible, downloadable, immutable and re-sellable which are all unique qualities of an NFT transaction. The company expects to develop many additional use cases for its NFT enabled marketplace. Nextech AR CEO and founder Evan Gappelberg stated that the company is toiling hard in the AR segment to introduce its new technology in the market, which includes a live volumetric human hologram in their AiRShow app. The company is focusing on providing the AR room to the consumer market as a standalone product. While the company has the AR technology intergrated as a part of their events platforms, they will soon be launching this enhanced version of Zoom lookalike with AI and AR technology. Gappelberg was notably pleased that Nextech’s Virtual Experience Platform (“VXP”) was chosen to host the Student Veterans of America’s (“SVA”) 2021 National Conference in February. This event showcased a keynote address by first lady Dr. Jill Biden and other imminent speakers such as author Gary Vaynerchuk, actress, neuroscientist, and author Mayim Bialik, and Secretary of Veterans Affairs Denis McDonough (https://ibn.fm/y3jOM). Nextech successfully launched its Ad network, which is run by former MSFT ad network president Hareesh Achi, which will further strengthen the company’s stance as a power player in the Augmented reality ecosystem. The Ad Network generated a over 1million impressions during a test at the recently held virtual and hybrid events for Repticon who hosts 100 events annually and the North Carolina Association of Zoning Officials (“NCAZO”) Annual Conference. With the launch of the AR Ad Network, Nextech is now uniquely positioned to deliver native ads and augmented reality solutions for the hybrid events for its enterprise customers who include: Amazon, Viacom, Johnson and Johnson, Bell Canada, Grundfos, UNESCO, Dell Technologies, Luxottica, Vulcan Inc, TEDx, Arch Insurance and others (https://ibn.fm/hAWUe). According to Grandview Research the global virtual events market in 2020 is $90B and expected to reach more than $400B by 2027, growing at a 23% CAGR (https://ibn.fm/2pDen). With Nextech’s VXP platform having augmented reality, AI, end-to-end encryption and built in language translation for 64 languages, the company is well positioned to rapidly take market share as the growth accelerates globally For more information, visit the company’s website at www.NextechAR.com. NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF